Edition:
United States

Sihuan Pharmaceutical Holdings Group Ltd (0460.HK)

0460.HK on Hong Kong Stock

3.38HKD
10:36pm EDT
Change (% chg)

HK$-0.02 (-0.59%)
Prev Close
HK$3.40
Open
HK$3.40
Day's High
HK$3.43
Day's Low
HK$3.36
Volume
2,764,000
Avg. Vol
36,965,943
52-wk High
HK$3.76
52-wk Low
HK$1.64

Latest Key Developments (Source: Significant Developments)

Sihuan Pharmaceutical Holdings announces establishment joint venture
Monday, 12 Jun 2017 05:38am EDT 

June 12 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd <0460.HK>::Croma-Pharma recently received China food and drug administration-approval for Princess Volume dermal filler.Establishes joint venture on minimally-invasive aesthetic products.‍Sales of Princess Volume dermal filler is expected to start as early as July 2017​.  Full Article

Sihuan Pharmaceutical updates on deal with Buchang Pharma regarding distributorship of two products
Tuesday, 16 May 2017 10:43am EDT 

May 16 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd <0460.HK>::Company has recently entered into an agreement with Buchang Pharma with respect to distributorship of two products."Currently, Buchang Pharma has 100% equity interests in Tonghua Guhong, and intends to terminate distributorship arrangement with group".Following disposal of 50% interest in Jilin Sichang, group intends to retrieve its nationwide distributorship of Qunao from Buchang.As per distribution deal between co & Buchang, arrangement between Tonghua Guhong and Buchang on Guhong product shall be terminated.As per distribution deal between co & Buchang, arrangement between Jilin Sihuan and buchang on Qunao Product shall also be terminated.  Full Article

Sihuan Pharmaceutical posts FY profit attributable of RMB 1.71 bln
Tuesday, 28 Mar 2017 06:16pm EDT 

Sihuan Pharmaceutical Holdings Group Ltd <0460.HK> : Board recommends declaration and payment of a final cash dividend of RMB3.8 cents per share and a special cash dividend of RMB5.5 cents per share . FY revenue RMB3.19 billion, up 0.6 pct .FY profit attributable to owners of company RMB 1.71 billion versus RMB 2.06 billion.  Full Article

Sihuan Pharmaceutical says unit entered into an equity acquisition agreement with Ambest Pharmaceutical
Wednesday, 22 Mar 2017 06:27am EDT 

Sihuan Pharmaceutical Holdings Group Ltd <0460.HK> : Sun Moral International (hk) recently entered into an equity acquisition agreement with Ambest Pharmaceutical Company Limited .Agreement to acquire 100% equity interest held by transferor in ambest pharmaceutical for rmb1.1 billion.  Full Article

Sihuan Pharmaceutical Holdings Group says HY revenue RMB 1.39 billion, down 21.8 pct<0460.HK>
Tuesday, 23 Aug 2016 10:01am EDT 

Sihuan Pharmaceutical Holdings Group Ltd <0460.HK>: Announcement of interim results for the six months ended 30 June 2016 <0460.HK> . HY profit attributable to owners of the company decreased by 49.3% to approximately RMB736.0 million . Interim dividend of RMB1.4 cents per share was declared by the board . It is expected that the government will maintain tight control over excessive growth in medical expenditure . Says HY revenue RMB 1.39 billion, down 21.8% . Lowering of provincial drug tender prices and implementation of "two-invoice system" to continue to pressure the pharmaceutical industry . Says rigid demand in the domestic pharmaceutical market will continue to grow .  Full Article

Sihuan Pharmaceutical Holdings Group Ltd announces collaboration with Raqualia
Tuesday, 22 Dec 2015 02:41am EST 

Sihuan Pharmaceutical Holdings Group Ltd:Voluntary announcement - collaboration with Raqualia in novel analgesic drugs and ion channel technology development.Shandong Xuanzhu Pharma, a wholly-owned subsidiary of the group, and Raqualia Pharma, entered into a research collaboration agreement.Raqualia and the group will work collaboratively to identify valuable drug candidates during the three-year collaboration.Group will be granted with exclusive rights to develop, manufacture and market the drug candidates in the Greater China region.  Full Article

Sihuan Pharmaceutical Holdings Group Ltd updates on arrest of Zhang Jionglong
Tuesday, 1 Dec 2015 04:44am EST 

Sihuan Pharmaceutical Holdings Group Ltd:Says Zhang was subsequently released on bail without any charges.Informed by Zhang Jionglong he was arrested by the independent commission against corruption of Hong Kong.Clarifies that issue has not affected and will not affect the normal business and operations of group.Arrest in connection with investigation into offence or offences suspected, inter alia, under prevention of bribery ordinance.  Full Article

Sihuan Pharmaceutical Holdings Group Ltd resolved to declare an interim dividend
Monday, 31 Aug 2015 06:17am EDT 

Sihuan Pharmaceutical Holdings Group Ltd:Resolved to declare an interim dividend of 1.4 yuan cents per Share.Payable on or around 23 September 2015 to the shareholders of the Company whose names appear on the register of members of the Company at the close of business on 17 September 2015.  Full Article